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Background: Protein-energy wasting (PEW) is common in hemodialysis patients and is a powerful predictor of
morbidity and mortality. Although much progress has been made in recent years in identifying the causes and
pathogenesis of PEW in hemodialysis patients, actual management by nutritional interventions is not always able to
correct PEW. Some investigators suggest that physical exercise may increase the anabolic effects of nutritional
interventions, and therefore may have a potential to reverse PEW. The aim of this study is to investigate the effect
of intra-dialytic progressive exercise training and adequate nutritional supplementation on markers of PEW,
functional capacities and quality of life of adult hemodialysis patients.
Methods and design: Fifty end-stage renal disease patients undergoing hemodialysis, who meet the diagnostic
criteria for PEW, will be randomly allocated into an exercise or control group for 6 months. The exercise consists of a
progressive submaximal individualized cycling exertion using an adapted cycle ergometer, during the three weekly
dialysis sessions. Biological markers of nutrition (albumin, prealbumin) will be followed monthly and all patients will
be assessed for body composition, walk function, muscle strength, postural stability and quality of life at baseline
and during the eighth week (t+2), the sixteenth week (t+4) and the twenty-fourth week (t+6) of the 6-month adapted
rehabilitation program.
Discussion: The successful completion of this current trial may give precious clues in understanding PEW and
encourage nephrologists to extend prescription of exercise programs as well as therapeutic and as preventive
interventions in this high-risk population.
Trial registration: The protocol for this study was registered with the France Clinical Trials Registry NCT01813851.
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Serum albumin < 3.8 g per 100 ml
Serum prealbumin < 30 mg per 100 ml
Serum cholesterol < 100mg per 100 ml
Body mass:
BMI < 23
Unintentional weight loss over time: 5% over 3 months
or 10% over 6 months
Total body fat percentage < 10%
Muscle mass:
Muscle wasting: reduced muscle mass 5% over 3 months
or 10% over 6 months
Reduced mid-arm muscle circumference area





Unintentional low dietary protein intake <0.80 g.kg-1.day-1
for at least 2 months
Unintentional low dietary energy intake <25 kcal.kg-1.day-1
for at least 2 months
*At least three out of the four listed categories (and at least one test in each
of the selected category) must be satisfied for the diagnosis of kidney disease
related PEW. Optimally, each criterion should be documented on at least three
occasions, preferably 2-4 weeks apart.
ISRNM, international society of renal nutrition and metabolism; PEW, protein-
energy wasting; BMI, body mass index.
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Nowadays, more than two million people are treated
worldwide by dialysis for end-stage renal failure [1]. Des-
pite significant progress in dialysis techniques and in the
treatment of associated comorbidities, hemodialysis (HD)
patients experience an impairment of their quality of life
and have a much higher risk of mortality compared to an
age-matched population. A sedentary lifestyle and an al-
tered nutritional status have been identified as major risk
factors for adverse outcomes in dialysis patients [2,3].
Dialysis patients have decreased physical functioning
(assessed by peak oxygen consumption ( _VO2max), phys-
ical performance tests, and self-reported functioning), di-
minished muscle mass and altered muscle quality, and all
of these features are associated with an increased mortality
risk [4-6]. These disturbances are directly related to renal
failure and comorbidities, and also to adverse effects from
medical treatments and from the dialysis itself. Dialysis in-
duces notable metabolic changes: hypovolemia due to
ultrafiltration, and rapid changes in electrolyte concentra-
tions and systemic inflammation, which can all adversely
affect physical function [7]. In addition, dialysis imposes
immobilization over 12–18 hours a week, thereby directly
contributing to sedentary behavior that can further
worsen the medical condition of HD patients. This vicious
circle can finally lead to the development of disability, loss
of independence, and death [8]. For all these reasons dialy-
sis patients have low levels of daily physical activity [9].
Therefore, it seems rational to promote programs for ex-
ercise training in this population.
In this vein, a large amount of literature published in the
past 30 years has documented a myriad of potential bene-
fits from exercise. Several include: increased maximal oxy-
gen uptake capacity ( _VO2max), improved blood-pressure
control [10], decreased arterial stiffness [11], decreased
systemic inflammation [12], improved solute removal by
dialysis [13,14], increased muscle mass, quality and force
[15], and favorable psychological adaptations (e.g., higher
perceived quality of life) [16]. Thus there is a large body of
evidence that the impact of end-stage renal disease
(ESRD) can be – for at least a significant part - counter-
acted by exercise training [7,17-20].
Along with this altered overall physical functioning,
malnutrition is highly prevalent in the ESRD population,
and is well-documented to be a strong predictor of mor-
tality. Significant evidence comes from the data of large
observational trials (USRDS, DOPPS [1-21]) showing that
malnourished dialysis patients have an increased risk of
mortality [22,23]. In this context, the International Society
of Renal Nutrition and Metabolism (ISRNM) has recom-
mended the term “protein–energy wasting” (PEW) to de-
scribe the loss of body protein mass and fuel reserves and
have defined the diagnostic criteria for this state (see
Table 1).All these criteria are individually associated with an
increased risk of adverse outcome so it can be assumed
that the concomitant presence of at least three criteria
is an even more powerful predictor of morbidity and
mortality. However, to the best of our knowledge, until
now no report exists about the prevalence and clinical
outcomes of PEW (as defined by the ISRNM). It can
be noted, however, that a large observational French
study reported that 36% of HD patients had a prealbu-
mine < 300 mg/dl, 20% had albumin < 35 g/l and 62%
a diminished lean body mass (LBM) < 90% [24].
The mechanisms causing PEW are complex and multi-
factorial: low nutrient intake (sometimes due to dietary
restriction), loss of nutrients into dialysate, abnormalities
that stimulate protein degradation and/or decrease pro-
tein synthesis. On this last point, we can include the
production of inflammatory cytokines, oxidative and car-
bonyl stress, endocrine disorders (hyperparathyroidism,
hypogonadism, diabetes, decreased insuline/insuline like
growth factor (IGF) signaling), acidosis, electrolyte
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activity causes the loss of muscle mass and force and
thereby directly contributes to worsen PEW. Traditional
management of PEW according to international guide-
lines (coming from the EBPG working group on nutri-
tion [26]) consists of dietary counseling, oral nutritional
supplements, enteral feeding, and in severe cases, the
use of intradialytic or total parenteral nutrition. Several
studies, however, have shown that these interventions
are not always able to correct PEW [27].
Simultaneously, considerable literature has pointed out
the anabolic effects of physical activity. For example,
both strength and endurance exercise induce transcrip-
tional changes in genes (IGF, myostatin) favoring ana-
bolic muscle [28]. Morevover, histologic and computed
tomography studies have clearly demonstrated a de-
crease in muscle atrophy and an improvement of the
overall muscular structure and quality (increased pro-
portion of type II, oxydative fibers) [29]. There is also
some evidence that intradialytic exercise, combined with
oral or parenteral nutrition, enhances amino acid uptake
and protein accretion in the muscles of HD patients
[30,31]. Strong arguments exist for programming the
adapted exercise training during the dialysis session ra-
ther than on non dialysis days, as there is better adher-
ence by patients who feel safer doing exercise under
medical monitoring, as a the counteraction to the inactiv-
ity due to the dialysis session, and due to a greater removal
of uremic toxins (as shown for urea (KT/V) and phos-
phorous) by improved tissue mobilization. In addition, ac-
cording to the large amount of published clinical trials,
the risks of prescribing exercise even in this frail popula-
tion are limited and the benefits largely prevail. Musculo-
skeletal injuries and cardio-vascular events are the most
common risks of physical exercise. Both types of adverse
events occur more frequently with high-intensity exercise
than with submaximal exercise [32]. In this present trial,
patients will be advised to exercise at a moderate level of
perceived exertion and will be under continuous supervi-
sion by medical personnel. It should also be mentioned
that European guidelines on nutrition in HD patients ex-
plicitly recommends regular physical exercise [26].
In sum, there are strong arguments in the literature to
prescribe exercise in HD combined with nutritional in-
terventions in patients suffering from PEW in an at-
tempt to enhance the anabolic effects of nutrition and
hereby reverse this high-risk state.
Specific aims
The aim of this randomized controlled trial is to
analyze the impact of a progressive intra-dialytic exer-
cise program combined with nutritional support fol-
lowing current guidelines on nutritional parameters
defined for PEW and its potential to reverse PEW. Inaddition, this trial will study the effect of intradialytic
exercise on functional performance (walking, postural
control, and muscular strength), body composition and
health-related quality of life in HD patients.
Methods and design
Study design
This study is a multicenter, open-label randomized con-
trolled trial. The study will be conducted at the outpatient
HD Laennec Dialysis unit and Confluent Dialysis unit of
the ECHO Dialysis Association. HD patients will be ran-
domly distributed into a control or an exercise group. The
randomization sequence of the participants will be gener-
ated by a computer program. A bio-statistician not in-
volved in recruitment and assessment will perform the
randomization.
The present study was approved by the Ethical Com-
mittee of Nantes Ouest IV (reference: ID RCB n°2012-
A01662-41), and was conducted in accordance with the
Declaration of Helsinki (last modified in 2004). All par-
ticipants will receive written and verbal information
about the aims and procedures of the study and will sign
a consent form to participate in the study.
Participants’ recruitment
All of the 210 patients treated by hemodialysis or online-
hemodiafiltration in the participating centers will be
screened for the presence of criteria for PEW. The princi-
pal investigators will review the existing patients’ database
for serum albumin, serum prealbumin, C-reactive protein
(CRP) levels, body mass index (BMI) and the presence of
weight loss according to the PEW criteria. Potential sub-
jects will have additional tests (measure of lean body mass
index by bio-impedance and a 3-day dietary record by a
qualified dietician in order to evaluate their protein and
energy intake). Patients fulfilling inclusion/exclusion cri-
teria and having signed an informed consent for the study
participation will undergo randomization generated by a
computer program. We expect to recruit approximately
fifty HD patients for this study.
Inclusion criteria
 Adult patients, male or female (Age > 18 years).
 Minimum hemodialysis vintage of 3 months.
 Stable on HD, in gender.
 No recent hospitalization.
 No acute or chronic medical conditions that would
make exercise training potentially hazardous or
primary outcomes impossible to assess.
 Patients who meet the following criteria for PEW
(according to [25]), meeting at least three out of the
four listed categories and at least one test in each of
selected category:
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level < 38 g/L (Bromcresol Green), or serum
prealbumin < 300 mg/L,
– Body mass criteria: BMI < 23 kg/m2, or
unintentional weigh loss > 5% over 3 months or
> 10% over 6 months,
– Muscle mass criteria: lean body mass (LBM)
estimated by bioimpedance spectroscopy
(Body Composition Monitor (BCM) Fresenius,
Bad Homburg, Germany) lower than the
10th percentile of an aged-matched normal
population. This method is validated in dialysis
patients [33,34].
– Dietary intake criteria: Unintentional low dietary
protein intake < 1 g/kg of ideal weight/day for at
least 2 months, unintentional low dietary energy
intake < 30 kcal/kg of ideal weight/day for at least
2 months.
 Informed consent of the patient.
Exclusion criteria
 Contraindication or inability to perform the physical
exercise.
 Inadequate dialysis Kt/V < 1.2.
 Presence of a cardiac pacemaker (incompatible with
the BCM measures).
 Systemic inflammation CRP > 20 mg/l.
 Pregnant woman.
 Patient under guardianship.
 Participation in another clinical interventional trial.
 Unstable on dialysis.
Intervention
All the patients will continue their usual dialysis proced-
ure (HD or HDF). No modifications of dialysis modality
or prescriptions are allowed except for adaptation of dry
weight using clinical criteria.
Both patients in the control and exercise groups will re-
ceive dietary counseling by a trained dietician. The pre-
scription of oral nutritional complements or intradialytic
parenteral nutrition will be adapted to patient needs ac-
cording to the dietary record in order to attain goals set
by the EBP guidelines for gender energy intake 30–40
kcal/kg of ideal weight/day, and protein intake > 1.1 g/kg
of ideal weight/day.
Exercise group
A 6-month adapted rehabilitation program will be con-
ducted by means of progressive submaximal individual-
ized cycling exercise, consisting of three sessions per
week. The exercise will be prescribed during the first
two hours of dialysis session using an adapted cycle erg-
ometer (« Reck moto-med letto ») that allows cycling ina supine position at different resistance levels. The
cycle ergometer displays the number of revolutions per
minute, the power developed and the distance virtually
traveled. For the patient, these types of visual feedback
are motivational factors that are recognized in the lit-
erature [35]. Further, it should be noted that this cycle
ergometer also allows for passive motorized pedaling
(i.e., the patient can pedal without effort).
The aim of this 6-month individualized program is to
reach a 30 min duration of continuous cycling at a mod-
erate exercise intensity, which corresponds to the level
“3 – moderate” on the Borg Rating Perceived Exertion
(RPE) scale (graduated from 0 to 10, where 0 = no effort
at all, and 10 = most extreme effort imaginable). Accord-
ing to recommendations issued from a large scale meta-
analysis [36], the exercise will be initially performed at
this intensity exercise perceived as moderate by the pa-
tient on the RPE scale (i.e., level 3). We deliberately
chose this method based on the patient’s rating percep-
tions rather than a method based on the heart rate as-
sessment because many dialysis patients have automatic
impairment or drug treatments that can interfere with
the heart rate control. This method is readily accessible,
reproducible and easy to use. Several exercise training
intensity levels at 50% to 85% of the maximal oxygen
consumption correspond consistently to ratings of 3–7
levels on the Borg RPE scale [37].
To estimate the targeted moderate exercise intensity,
an exercise protocol with an increasing intensity on the
cycle ergometer will be performed at the inclusion, be-
fore the rehabilitation program. During this first evalu-
ation, after a warm-up of 5 minutes without resistance,
the patient will pedal with a self-selected chosen cadence
against an increasing resistance imposed by the cycle
ergometer, until the patient reaches a level perceived as
moderate, namely level 3 on the Borg RPE scale. A simi-
lar monthly assessment will be realized to update the in-
tensity of cycling exercise. During these sessions, the
patient will be regularly asked about level of shortness of
breath, any feelings of fatigue and pain, with a visual
analogue scale (0–10 cm), in order to reduce the exer-
cise intensity if necessary.
During a dialysis session, the cycling exercise will be
performed in the first half of the session. After a 5 min
warm-up without resistance, the patient will gradually
reach the intensity corresponding to level 3 on the Borg
RPE scale. Then the patient will be instructed to main-
tain this cycling exercise intensity for at least 10 minutes
during the first month, 15 minutes during the second
one, 20 minutes for the two next months in order to
achieve the targeted exercise duration of 30 minutes in
the two last months. The first target is to observe an
evolution of their functional capacity/performance over
time. Finally, a period of active recovery (pedaling
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aling recovery will end the exercise session. Blood pres-
sure and heart rate will be measured at the beginning
and the end of the exercise session. Heart rate will be
maintained below 70% of maximum heart rate during
the cycling exercise. At the end of the dialysis session,
the HD patient will be asked to estimate pain level, bore-
dom level and mood as perceived during the session,
with a visual analogue scale graduated from 0 to 10.
Nephrologists, nurses, and a specialist in adapted phys-
ical activities will monitor the patient.
Control group
Similarly, at the end of each dialysis session, the “con-
trol” patient will be asked to estimate his pain level,
boredom level and mood perceived during the session,
with a visual analogue scale graduated from 0 to 10 [38].
Outcome measures
All the measures listed below will be assessed at the
baseline t0, and during the eighth week (t+2), the six-
teenth week (t+4) and the twenty-fourth week (t+6) of the
6-month adapted rehabilitation program.
Primary outcome measures
The primary outcome of this study is the number of pa-
tients who are no longer in a state of protein energy
wasting after 6 months of exercise training compared to
the control group. We define correction of PEW as the
normalization of albumin and prealbumine, and of the
lean tissue index, considering these items to be the clin-
ically most relevant for the diagnostic criteria of PEW.
Biological sample
Patients in both groups will have routine serum chemistry
measures according to follow-up guidelines for dialysis pa-
tients in terms of serum electrolytes, -bicarbonate, s-urea
and creatinine, urea reduction rate, KT/V monthly, PTH
and 25 OH vitamine D, which will be measured at the be-
ginning and at the end of the study. Patients will receive
oral native vitamin D supplementation in order to main-
tain serum 25 OH levels in the normal laboratory range.
Dietetics survey
Protein and energy intake will be assessed by a qualified
dietitian by means of a 3 day food record at the begin-
ning and at the end of the study.
Secondary outcome measures
Secondary outcome measures include: (i) changes in bio-
logical markers of nutrition (albumin and prealbumine),
body composition (LTI, FTI), muscle strength, walk func-
tion, postural stability, quality of life, days of hospitalization,
and survival.Biological markers of nutrition (albumin and prealbumine)
Serum albumine and -prealbumine will be measured
monthly. BMI will be calculated at month t+2, t+4 and t+6.
Serum albumine is measured by the bromcresol green
method (normal range (38–52 g/l), serum prealbumine is
measured by the immune-turbidimetric method (normal
range 300–400 mg/l).
Body composition
Body-composition (overhydration, lean tissue index
(LTI, kg/m2) and fat tissue index (FTI, kg/m2) will be
measured by bioimpedance spectroscopy using a Body
Composition Monitor (BCM, Fresenius Medical Care,
Bad Homburg, Germany) at month 2, 4 and 6 just be-
fore the midweek dialysis session.
Walk function
The walk function assessment will be performed using a
6 min-walk-test (6MWT). This test has been considered
to be an appropriate test to assess a patient’s functional
and physiological response and cardiovascular fitness
[39]. Patients will walk along a measured circuit (15 m),
and are instructed to cover as much distance as possible
in the six minutes. Blood pressure, heart rate and rating
perceived exertion (RPE) will be assessed before and
after the 6MWT.
Muscle strength
Maximal quadriceps strength during a knee extension
will be tested using a manual dynamometer (Metil In-
dustry©, Belgium). Patients will perform three maximal
leg extensions in sitting position before a dialysis session.
At least five minutes of recovery will be provided be-
tween 2 consecutive measurements.
Quality of life
The self-reported quality of life will be evaluated using
the Medical Outcome Study Short Form 36 (SF-36)
[40-42], which has been documented to be reliable and
valid in dialysis patients [10,43]. This SF-36 is a generic
multidimensional instrument consisting of eight multi-
item scales representing: (1) physical functioning (extent
to which health limits physical activities, such as self-care,
walking, and climbing stairs), (2) social functioning (extent
to which physical health or emotional problems interfere
with normal social activities), (3) role-functioning physical
(extent to which physical health interferes with work or
other dally activities), (4) role-functioning emotional (ex-
tent to which emotional problems interfere with work or
other daily activities), (5) mental health (general mental
health, including depression, anxiety, behavioral and emo-
tional control, and general positive effect), (6) vitality (feel-
ing energetic and full of pep rather than tired and worn
out), (7) bodily pain (intensity of pain and effect of pain
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(8) general health perceptions (personal evaluations of
current health, health outlook, and resistance to illness).
Postural stability
Balance during a quiet stance will be tested after a rest
period before the dialysis session. The postural test will
consist of two conditions of quiet stance: stance on a
firm surface with eyes open (EO) and stance on a firm
surface with eyes closed (EC). Participants will stand
quietly while barefoot, with the head in a straight-ahead
position, their arms along the body. During conditions
with eyes open, they will be instructed to look at a black
spot (with a diameter 2 cm diameter) placed on a white
wall in the front of them at a 2 m distance. For each
condition, two trials will be performed. The duration of
each trial will be 60 s followed by a rest period of 1 minute.
During thee condition with EO, the subject’s eyes will focus
on a stationary eye-level visual target (a black spot with
a 2 cm diameter) situated at a 2 m distance. For all data
collection of postural sway, we will use a Kistler force pla-
teform (model 9286BA) with subject weight normalization.
Data will be sampled at 100 Hz and recorded online. The
body sway will be quantified by displacement of the center
of foot pressure (COP) in the anterior-posterior (AP) and
in the medial-lateral direction (ML). For measuring all of
the COP parameters, raw data will be filtered using a
fourth-order Butterworth, zero-phase low-pass at 10 Hz.
The COP parameters will then be the mean and standard
deviation (SD) of COP position in AP and ML directions,
SD of velocity in AP and ML directions, mean velocity
and area (90% confidence ellipse) (see [44] for details of
formulas).
Statistical analysis
The sample size was calculated considering the number
of patients who are no longer in a state of protein energy
wasting after 6 months of exercise training compared to
the control group. For a significance level of 0.05 and
80% power, it was estimated that 22 participants would
be required in each group.
Results will be expressed as minimum to maximum
or percentage of change, as applicable, and mean ±
standard deviation. To test the effects of Group (Exer-
cise versus Control) on all outcome measures, univari-
ate two-way analyses of variance (ANOVAs), with the
Group (×2) as between-subjects factor and Time (t0, t+2,
t+4 and t+6) as the within subject factor, will be carried out
for each aforesaid dependent variable. For each analysis,
the level of significance was p < 0.05. Newman-Keuls
comparisons will be used for post-hoc tests following sig-
nificant effects. If the sphericity assumption in ANOVA is
violated (Mauchly’s test), corrected tests of significance
will be used [45,46]. In that case, the paired t-tests withcorrected alpha level will be used as post-hoc compari-
sons. All the statistical analyses will be conducted using a
SPSS software package.
Discussion
To our knowledge, this is the first trial investigating the
impact of intradialytic exercise combined with an indi-
vidualized nutritional support on protein energy wasting.
It is also the first trial to investigate the influence of ex-
ercise on postural balance, which is of special interest
for fundamental and clinical purposes (i.e., the important
issue of physical condition in dialysis patients). An im-
proved postural balance signifies a decreased incidence
of falls and fractures in this high-risk population [47].
The main forces of this trial will be the randomized de-
sign and the individualized management of “real life” pa-
tients suffering from PEW. It can be argued that the
nutritional support will not be the same in all patients as
some will have only nutritional counseling and others
ONC and a few IDPN. However, according to the litera-
ture the different nutrition methods have equivalent effi-
cacy and the prescription of the type of nutritional
support will follow actual guidelines. If this current clin-
ical trial can highlight the expected effects of exercise to
reverse PEW, at least for a part, it would be a strong ar-
gument for implementing an exercise program in this
high-risk population and even in the whole dialysis
population in order to prevent the occurrence of PEW.
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